PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.\', \'Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.\', \'Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.\', \'Viapath Analytics, Guy\'s and St Thomas\' NHS Foundation Trust, London, UK.\', \'Gastroenterology, Barts and The London NHS Trust, London, UK.\', \'Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK.\', \'Gastroenterology and Hepatology, Inflammatory Bowel Disease Center, Radboud University Medical Center, Nijmegen, the Netherlands.\', \'Biochemistry, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.\', \'Infection & Immunity Sciences, North West London Pathology, London, UK.\', \'Biochemistry, Sandwell & West Birmingham NHS Trust, Birmingham, UK.\', \'Metabolism, Digestion and Reproduction, Imperial College London, London, UK.\', \'Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.\', \'Infectious Diseases, Imperial College Healthcare NHS Trust, London, UK.\', \'Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry Blizard Institute, London, UK.\', \'Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.\', \'Gastroenterology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.\', \'School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.\', \'IBD Unit - Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK.\', \'Hull York Medical School, University of Hull, Hull, UK.\', \'Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.\', \'Gastroenterology, Guy\'s and St Thomas\' Hospitals NHS Trust, London, UK.\', \'School of Immunology & Microbial Sciences, King\'s College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ecco-jcc/jjab153
?:doi
?:hasPublicationType
?:journal
  • Journal of Crohn\'s & colitis
is ?:pmid of
?:pmid
?:pmid
  • 34473254
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all